Antibiotic resistance in Helicobacter pylori infection
|
|
- Vanessa Marshall
- 7 years ago
- Views:
Transcription
1 Antibiotic resistance in Helicobacter pylori infection Francis Megraud haboratoire de Bacteriologie, Hopital Pellegrin, Bordeaux, France Resistance to antibiotics is considered as the primary reason for failure of eradication therapies. Resistance to clarithromycin is due to a decrease in binding to the ribosomes associated with a point mutation on the 23S rrna. Its rate in Europe varies from 0-15%, with 5% in the UK. The resistance influences dramatically the success of the treatments. Resistance to metronidazole is due to a lack of reduction of this compound whose genetic basis is still unknown. The resistance rate in Europe varies from 10-50%, with 25% in the UK. It influences the success of treatments to a lesser extent than clarithromycin resistance. The initial eradication treatment can be prescribed without testing for susceptibility and must include a combination of two antibiotics, while stressing the importance of compliance to the patient. In case of failure, susceptibility testing must be performed. Few data are currently available on alternative therapeutic strategies when H. pylori is resistant to both clarithromycin and metronidazole. Despite the fact that the optimal treatment for Helicobacter pylori infection has not been found, there are several combinations of drugs which can cure the infection in up to 80-90% of cases 1. There are several possible explanations for failure, such as a lack of compliance from the patient, but the main reason to date seems to be the occurrence of strains which are resistant to the antibiotics used 2. Among the compounds recommended for eradication of H. pylori, resistance occurs frequently with macrolides and nitroimidazoles but never with amoxicillin and tetracycline, although some anecdotal reports exist for the latter two (Table 1). This review will present current data concerning the mechanisms and the epidemiology of the resistance and consider ways to deal with this problem in clinical practice. Correspondence to Prof. Resistance mechanisms Laboratoire de Resistance to macrolides 'pellegrin, Macrolides are a group of antibiotics with a lactone ring of which Bordeaux cedex. France erythromycin is the leader. These antibiotics are administered orally, British Medical Bulletin 1998;54 (No. 1): O The British Council 1998
2 Helicobacter infection Table 1 MIC of different antibiotics on susceptible and resistant strains of H. pylori (mg/l) Amoxicillin Clarithromycin Metronidazole Tetracycline Ciprofloxacin Susceptible strains Resistant strains 4-64 >8 >2 they diffuse well in tissue, have a narrow spectrum and limited side effects. They are used to treat H. pylori infection in association with a second antimicrobial agent, either amoxicillin or a nitroimidazole compound, and an antisecretory drug. The most attractive compound to date is clarithromycin because it has the best efficacy in vitro. It is moderately affected by a decrease in ph, and good concentrations can be obtained in gastric mucosa. Once macrolides have penetrated into the bacterial cell, they bind tightly to ribosomes where protein synthesis takes place. The exact site of action is the peptidyl transferase loop of domain V of the 23S ribosomal RNA. In the event of resistance (MIC > 2 mg/l), there is a decreased affinity between ribosomes and clarithromycin 3. This property has been found to be associated with a point mutation in the 23S rrna gene in position 2143 (formerly 2058 in the Escherichia coli nomenclature) and 2144 (formerly 2059) 4. This result has been confirmed by others including studies on European strains 3 " 5 ' 6. The mutation is essentially a transition A >G but may be a transversion A»C in position 2143 in some cases 7. Detection of this mutation is possible after PCR using adequate primers amplifying part of the 23S rrna gene followed by sequencing or restriction with the enzymes Bsal (A2143G) and Bbsl (A2144G) but not A2143C. Recently, methods based on hybridization of the amplified products have been proposed, such as the PCR-oligonucleotide ligation assay*. Resistance to nitroimidazoles Metronidazole and tinidazole are the compounds in this class used to treat H. pylori infection. Cross resistance between these two drugs exists. The essential differences between them relate to their pharmacodynamics and safety profiles. To be active, metronidazole must penetrate into the bacteria. Subsequently, the NO 2 group of the nitroimidazole compound is reduced to form a hydroxylamine derivative. The reduced product causes damage to the DNA thereby causing cell death. 208 British Medical Bulletin 1998;54 (No. 1)
3 Antibiotic resistance Smith and Edwards studied drug uptake and the rate of cell killing of metronidazole against H. pylori and found it dependent upon the relative oxygen tension of the environment and the cell density, both of which determine the redox conditions of the media 9. These results are in agreement with the work of Cederbrant et al who showed diat in vitro metronidazole resistance could disappear when the strains were incubated anaerobically for a few hours before growth The low redox potential thus achieved led to an increased reduction of metronidazole, the active compound generated. The mechanism which renders the metronidazole resistant strains of H. pylori susceptible after a short anaerobic incubation is not yet known. The activation of an anaerobic metabolic pathway which does not function under microaerobic conditions could be the cause and would also explain the apparent non-stable resistance 12, since the atmosphere of incubation is not fully controlled during subculture of the strains. The genetic mechanism which underlines the resistance is not yet known 13 and, therefore, a molecular detection is not possible. Resistance to fluoroquinolones While fluoroquinolones are not routinely included in current regimens used to treat H. pylori infection, ciprofloxacin is sometimes used in the event of resistance to previously employed compounds. Fluoroquinolones interfere with DNA gyrase, an enzyme acting on the supercoiling of DNA during cell replication. In one study, resistance was found associated with four groups of point mutations in the gyra gene 14. A cross resistance also exists for this group of compounds. Resistance to tetracydines While currently not used extensively, tetracyclines are a component of the bismuth-based triple therapy regimen which was recommended in 1990 to treat H. pylori infection. Their site of action is the ribosome. It is thought that H. pylori does not acquire resistance to tetracyclines. However, this conception must be reconsidered following a recent description of a resistant strain in Australia 15. More information is needed, particularly with regards to the mechanism of action. Resistance to $-lactams Amoxicillin is the pmactam most commonly used in the regimens aiming to eradicate H. pylori. One might ask why H. pylori has not acquired resistance to this drug while, during more than 20 years, tons of amoxicillin have been used. British Medical Bulletin 1998;54 (No. 1) 209
4 Helicobacter infection The main mechanism of resistance in this group is linked to the production of P-lactamase, a resistance commonly found in Gramnegative bacilli and staphylococci. It seems that the H. pylori restriction enzymes do not allow the introduction of exogenous DNA from phylogenetically distant bacteria. Moreover, the possible contacts between H. pylori and these bacteria are most likely to be limited unless one believes that H. pylori can multiply in the intestine. Nevertheless, P- lactamase genes can theoretically be transferred to H. pylori. A second mechanism of resistance is a modification of the target, i.e. the penicillin binding proteins. Several of them may be present in H. pylori. It is possible that, if a resistance occurs in the future, it will be by this mechanism, as was the case with Streptococcus pneumoniae in recent years. In this case, the levels of resistance are usually relatively low. MICs of amoxicillin against H. pylori are usually low ( 0.03 mg/1). It is, however, possible to find strains with MICs 10 times higher ( mg/1) which warrant further study. The small number found in clinical trials does not allow an association between these strains and treatment failure to be detected. Furthermore, Dore et al recently reported tolerance to amoxicillin, however, this phenomenon seems difficult to maintain in subcultures 16. For these reasons, susceptibility of H. pylori to amoxicillin must be monitored. Epidemiology of resistance Resistance to macrolides The frequency of resistance to macrolides varies from country to country and seems to parallel the use of this therapeutic class to treat other infections, mainly respiratory tract infections in the past. There is a north-south gradient. In Scandinavia where macrolides have rarely been used, the level of H. pylori resistance remains very low while the rate is 10-15% in Southern Europe. There is a tendency towards an increase in resistance in countries where macrolides have recently been introduced. In Belgium, for example, the resistance rate increased from 2.2% in 1990 to 11.1% in It is, therefore, mandatory to have a surveillance of H. pylori resistance to macrolides. Resistance to nitroimidazoles A marked difference has been found between the rate of resistance to nitroimidazoles in developed and developing countries. This difference 210 British Medial Bulletin 1998;54 (No. 1)
5 Antibiotic resistance may be linked to the high level of general use of metronidazole in developing countries, because these countries are mostly tropical countries and this inexpensive drug is commonly used to treat parasitic infections such as amoebiasis. Resistance rates can be as high as 80-90% in developing countries, as reported in Africa (Burkina Faso, Zaire). In developed countries, the rate of resistance ranged from 10-50% in a European multicenter study in The cause of this resistance may also be linked to the use of these compounds for genital infections, especially trichomonasis and, therefore, strains isolated from women are more likely to be resistant than strains isolated from men 18. Another possible cause may be the use of these compounds to treat dental infections. There is a trend towards an increased rate of resistance in developed countries. This may be due to an increased use of these compounds to treat H. pylori infection, because resistant organisms can easily emerge. However, this trend may not be of the magnitude suspected. Indeed, there are problems with regard to the technique used to detect this resistance. In our experience only MICs determined by agar dilution, and not Etest, correlate with the clinical outcome in clinical trials 19. Resistance to fluoroquinolones There have been very few surveys concerning resistance to fluoroquinolones. This resistance is usually reported to be less than 1%. Up until now, fluoroquinolones have been used mostly to treat severe infections in hospital settings and not in the community as is the case for macrolides. When they are used, the treatment lasts for a very short period. Hence, we can conclude that exposure to fluoroquinolones has been limited. Problems observed during the initial treatment for H. pylori These problems concern the possible existence of 'primary' resistance to the compound administered, as well as the possible occurrence of a secondary resistance to the treatment prescribed, both of which can lead to a treatment failure. 'Primary' resistance This is always the consequence of previous treatment with the antibiotic considered, even if the patient has no recollection of previously taking the drug. British Medical Bulletin 1998;54 (No. 1) 211
6 Helicobacter infection Eradication rate (% 100, Fig. 1 Estimated success rate with the triple therapy omeprazoledarithromycinamoxicillin according to the rate of resistance of H. pylori to clarithromycin Resistance rate to clarithromycin (%) The Maastricht consensus report states that susceptibility testing is not mandatory before prescribing the initial treatment 20. The treatment will then be 'probabilistic' and, therefore, must be based on epidemiological data of resistance, either national, or better yet regional. It is currently accepted that, with a resistance rate of H. pylori less than 15% to clarithromycin and less than 30% to metronidazole, it is still reasonable to use these drugs. It must be kept in mind that when there is resistance to one compound, a certain efficacy will come from the other compound. For instance, amoxicillin as the only antibiotic associated with an antisecretory drug which can lead to a 50% success rate and the rate increases to 70% for clarithromycin. The experted success rates according to the rate of resistance to clarithromycin for the omeprazole-amoxicillin-clarithromycin treatment are presented in Figure 1 and according to the rate of resistance Eradication rate (% Fig. 2 Estimated success rate with the triple therapy omeprazoleclarithromycinmetronidazole according to the rate of resistance of H. pylori to metronidazole Resistance rate to metronidazole (%) 212 British Medical Bulletin 1998,54 (No. 1)
7 Antibiotic resistance to metronidazole for the omeprazole-clarithromycin-metronidazole treatment are presented in Figure 2. These expected rates are based on the results of different clinical trials performed in Europe, i.e. ACT and MACH V 2. Secondary resistance Since the resistances concerned are acquired by mutation, it is important that the antibiotics always be present in sufficient quantities at the site of the infection to avoid the emergence of resistance. It is mandatory always to prescribe two antibiotics and to explain carefully to the patient that the compounds must be taken together and without interruption until the end of the 7 day period. Compliance to treatment is a key factor in preventing the occurrence of resistant strains. Problems occurring after failure of initial therapy Failure or eradication will be noticed either by a relapse of symptoms or by a positive test for H. pylori during post-therapy follow-up. Except under special conditions, i.e. gastric ulcer and gastric lymphoma, followup is performed by a [ 13 C]-urea breath test. This test is very specific and its sensitivity post-treatment is higher than 90%. Susceptibility testing of H. pylori to antibiotics In the event of a positive result, testing the susceptibility of H. pylori to antibiotics before prescribing a new eradication treatment is recommended. This is undoubtedly the main reason motivating H. pylori culture. H. pylori is a fragile and slow growing bacterium so it is advisable to refer to specialized laboratories for its culture. With regards to susceptibility testing, all techniques can be used for macrolides while the breakpoint method (8 mg/1) can be recommended for metronidazole and the Etest for amoxicillin. A delay of several days is needed in all cases before obtaining results. Management after failure of a first eradication therapy It is not possible to find answers to this question in the literature, because no trial has yet been performed. However, because cases of failure to eradicate H. pylori are becoming more frequent, such studies British Medical Bulletin 1998;54 (No. 1) 213
8 Helicobacter infection are urgently required. The approach outlined below is only subjective but is facilitated by knowledge of the susceptibility of H. pylori. If the initial antimicrobials given were clarithromycin and amoxicillin, in the event of clarithromycin resistance, metronidazole should be given. If the initial antimicrobials given were clarithromycin and metronidazole, in the event of clarithromycin resistance, amoxicillin should be given; and if there is a metronidazole resistance, amoxicillin can also be used. However, the situation becomes more complicated if the bacterium is resistant to both clarithromycin and metronidazole. The results of one unpublished trial indicate that the combination of amoxicillinmetronidazole is more effective when the dose of metronidazole is increased to 3 x 500 mg/day. Furthermore, it is advisable to increase the duration of treatment from 7 to 10 days. Other combinations, i.e. amoxicillin-tetracycline and amoxicillinciprofloxacin, should also be considered. Quadruple therapy may also be a good alternative. It consists of adding a proton pump inhibitor to standard triple therapy: bismuth salts-tetracycline-metronidazole 23. A new compound, ranitidine bismuth citrate (RBC), combines an antisecretory drug, ranitidine, and an antibacterial drug, bismuth salts, in one molecule. In association with clarithromycin for 2 weeks, RBC achieves eradication rates similar to proton pump inhibitor-based eradication regimens. When combined with two antibiotics, a quadruple therapy is then achieved and this combination given for 7 days may lead to high eradication rates 24. In case of failure without resistance, the same combination can be given a second time but for 2 weeks instead of 1 week, while stressing the importance of compliance. Conclusion In conclusion, H. pylori resistance to antibiotics is the first cause of failure of current eradication regimens. We can expect progress in the field of susceptibility testing, e.g. standardisation of the procedures and development of rapid tests. The main progress will, however, come from using simpler regimens to which H. pylori will not develop resistance. Nitazoxanide, a nitrothiazole compound similar to metronidazole which has this characteristic, is currently under study. Knowledge of the entire sequence of the H. pylori genome should permit the development of drugs which would target specifically vital functions of H. pylori in the near future. 214 British Medical Bulletin 1998;54 (No. 1)
9 Antibiotic resistance References 1 Van der Hulst RWM, Keller JJ, Rauws EAJ et al. Treatment of Helicobacter pylon infection: a review of the world Literature. Helicobacter 1996; 1: Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 (Suppl 1): Occhialini A, Urdaci M, Doucet-Populaire F et al. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997; 41: Versalovic J, Shortndge D, Kibler K et al. Mutations in 23S rrna are associated with clanthromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40: Debets-Ossenkopp YJ, Sparrius M, Kusters JG et al. Mechanism of clanthromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996; 142: Szczebara F, Dhaenens L, Vincent P et al. Evaluation of rapid molecular detection of clanthromycin resistance in Helicobacter pylori. Eur ] Clin Microbiol Infect Dis 1997; 16: Stone GG, Shortndge D, Versalovic J et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rrna gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 1997; 41: 712^ 8 Pina M, Occhialini A, Monteiro L et al. Rapid detection of point mutations associated with macrolide resistance in Helicobacter pylori using the Gen-eti-k DEIA hybridization kit. Gut 1997; 41(Suppl 1): A75 9 Smith MA, Edwards DI. The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori. ] Antimicrob Chemother 1995; 36: Cederbrant G, Kahlmeter G, Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. ] Antimicrob Chemother 1992; 29: Smith MA, Edwards DI. Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to mtroheterocyclic drugs. / Anttmicrob Chemother 1995; 35: Van Zwet AA, Thijs JC, de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995; 39: Hoffman PS, Goodwin A, Johnsen et al. Metabolic activities of metronidazole-sensitive and - resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. / Bacteriol 1996; 178: Moore RA, Beckthold B, Wong S et al. Nucleotide sequence of the gyrh gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 1995; 39: Midolo PD, Korman MG, Turnbridge JD et al. Helicobacter pylori resistance to tetracycline. Lancet 1996; 347: Dore MP, Sepulveda AR, Mura I et al. Explanation for variability of omeprazole-amoxicillin therapy? Tolerance of H. pylori to amoxjcilhn. Gastroenterology 1997; 112: A de Koster E, Cozzoli A, Vandenborre C et al. H. pylori resistance to macrolides increases, to imidazoles remains stable. Gastroenterology 1997; 112: A99 18 Glupczynski Y, the European Study Group on Antibiotic Susceptibility of H. pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in H. pylori. Eur J Clin Microbiol Infect Dis 1992; 11: Bouchard S, Birac C, Lamouliatte H et al. Correlation between the M1CS of metronidazole on H. pylori strains and the outcome of a lansoprazole-amoxicilline-metronidazole therapy. Gut 1996; 39 (Suppl 2): 1A05 20 Malfertheiner P, Megraud F, O'Morain C et al. Current European concepts in the management of Helicobacter pylori infection - the Maastricht consensus report. Eur] Gastroenterol Hepatol 1997; 9: 1-2 British Medial Bulletin 1998;54 (No. 1) 215
10 Helicobacter infection 21 Wurzer H, Rodrigo L, Stamler D et al. Short-course therapy with amoxicillin-clarithromycin triple for 10 days (ACT-10) eradicates H. pylori and heals duodenal ulcer. Aliment Pharmacol Ther 1997; 11: Megraud F, Lehn N, Lind T et al. The MACH 2 study. Helicobacter pylori resistance to antimicrobiol agents and its influence on clinical outcome. Gastroenterology 1997; 112: A de Boer W, Driessen W, Jansz A et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: Savarino, Mansi C, Mele MR et al. A new one-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. Aliment Pharmacol Ther 1997; 11: British Medical Bulletin 1998;54 (No. 1)
www.biochemj.org/bj/330/0581/bj3300581.htm
Ribosomes as Antibiotic Targets www.biochemj.org/bj/330/0581/bj3300581.htm Ware, Bioscience in the 21 st Century, 2009 PERSPECTIVE Widespread use of antibiotics after WWII improved human health globally
More informationReview of the evidence for H. Pylori treatment regimens. Dr Lennita Wannmacher
18th Expert Committee on the Selection and Use of Essential Medicines (21 to 25 March 2011) Review Section 17.1 (Antacids and other antiulcer medicines) -- Adults and children Review of the evidence for
More informationChapter 20: Antimicrobial Drugs
Chapter 20: Antimicrobial Drugs 1. Overview of Antimicrobial Drugs 2. Antibacterial Drugs 3. Antiviral Drugs 4. Drugs for Eukaryotic Pathogens 1. Overview of Antimicrobial Drugs Antibiotics An antibiotic
More informationGloucestershire Hospitals
TRUST GUIDELINE In the case of hard copies of this policy the content can only be assured to be accurate on the date of issue marked on the document. The Policy framework requires that the policy is fully
More informationPRIORITY RESEARCH TOPICS
PRIORITY RESEARCH TOPICS Understanding all the issues associated with antimicrobial resistance is probably impossible, but it is clear that there are a number of key issues about which we need more information.
More informationH. pylori Eradication Regimens
H. pylori Eradication Regimens 1-2-3 Cured March 1999 Highlights H. pylori eradication drastically reduces ulcer recurrence in patients with duodenal or gastric ulcers. 7-day triple therapies with a proton
More informationAntibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis
Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis ANTIBIOTIC-ASSOCIATED DIARRHEA Disturbance of the normal colonic microflora Leading to alterations in bacterial degradation
More informationMDM. Metabolic Drift Mutations - Attenuation Technology
MDM Metabolic Drift Mutations - Attenuation Technology Seite 2 Origin of MDM attenuation technology Prof. Dr. Klaus Linde Pioneer in R&D of human and animal vaccines University of Leipzig Germany Origin
More informationFrequently Asked Questions
Guidelines for Testing and Treatment of Gonorrhea in Ontario, 2013 Frequently Asked Questions Table of Contents Background... 1 Treatment Recommendations... 2 Treatment of Contacts... 4 Administration
More informationESCMID Online Lecture Library. by author
Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare
More information2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey
2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey Antibiotic resistance is a global issue that has significant impact in the field of infectious diseases.
More informationVancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4
Antibiotic Classes Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Assistant Professor of Clinical Medicine and Epidemiology Beta-lactams Inhibit cell wall synthesis Penicillins Cephalosporins
More informationPACKAGE LEAFLET. CLINDAMYCIN capsules Clidamycin. One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride).
PACKAGE LEAFLET CLINDAMYCIN capsules Clidamycin COMPOSITION One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride). One capsule of 150 mg contains 150 mg Clindamycin (as hydrochloride). PROPERTIES
More informationBiological Sciences Initiative
Biological Sciences Initiative HHMI Student Activities Measuring Antibiotic Resistance Introduction: You might be aware that antibiotics were once thought of as a magic bullet; a nearly perfect drug for
More informationBreath Hydrogen Tests
Breath Hydrogen Tests Breath hydrogen tests are very useful to help plan a low FODMAP diet. The tests have been around for many years - decades, in fact. However they were not regularly used in routine
More informationGenetics Lecture Notes 7.03 2005. Lectures 1 2
Genetics Lecture Notes 7.03 2005 Lectures 1 2 Lecture 1 We will begin this course with the question: What is a gene? This question will take us four lectures to answer because there are actually several
More informationWHEN AND HOW TO PERFORM SUSCEPTIBILITY TESTING. Manuel López-Brea & Teresa Alarcón Depart. of Microbiology Hospital Universitario de la Princesa
WHEN AND HOW TO PERFORM SUSCEPTIBILITY TESTING Manuel López-Brea & Teresa Alarcón Depart. of Microbiology Hospital Universitario de la Princesa Campylobacter Dr. Martin Skirrow 1977 2nd International
More information2. The number of different kinds of nucleotides present in any DNA molecule is A) four B) six C) two D) three
Chem 121 Chapter 22. Nucleic Acids 1. Any given nucleotide in a nucleic acid contains A) two bases and a sugar. B) one sugar, two bases and one phosphate. C) two sugars and one phosphate. D) one sugar,
More informationNational Digestive Diseases Information Clearinghouse
Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach
More informationTwincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie
Twincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie 0 HELMHOLTZ I ZENTRUM FÜR INFEKTIONSFORSCHUNG Technische Universität Braunschweig Institut
More informationNSAIDs and Peptic Ulcers
NSAIDs and Peptic Ulcers National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is a peptic ulcer? A peptic ulcer is a sore
More informationStatistical estimation using confidence intervals
0894PP_ch06 15/3/02 11:02 am Page 135 6 Statistical estimation using confidence intervals In Chapter 2, the concept of the central nature and variability of data and the methods by which these two phenomena
More informationManagement of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings
Management of Extended Spectrum Beta- Lactamase (ESBL) Producing Enterobacteriaceae in health care settings Dr. Mary Vearncombe PIDAC-IPC February 2012 Objectives: To provide an overview of the RP/AP Annex
More informationANTIBIOTIC INHIBITION OF BACTERIA
ANTIBIOTIC INHIBITION OF BACTERIA STANDARDS 3.2.10B, 3.2.12B Apply process knowledge and evaluate experimental information 3.3.10B, 3.3.12B Chemical and structural basis of living organisms Westminster
More informationEtiology and treatment of chronic bacterial prostatitis the Croatian experience
Etiology and treatment of chronic bacterial prostatitis the Croatian experience Višnja Škerk University Hospital for Infectious Diseases "Dr. Fran Mihaljevic" Zagreb Croatia Milano, Malpensa, 14 Nov 2008
More informationEffects of Antibiotics on Bacterial Growth and Protein Synthesis: Student Laboratory Manual
Effects of Antibiotics on Bacterial Growth and Protein Synthesis: Student Laboratory Manual I. Purpose...1 II. Introduction...1 III. Inhibition of Bacterial Growth Protocol...2 IV. Inhibition of in vitro
More informationIIID 14. Biotechnology in Fish Disease Diagnostics: Application of the Polymerase Chain Reaction (PCR)
IIID 14. Biotechnology in Fish Disease Diagnostics: Application of the Polymerase Chain Reaction (PCR) Background Infectious diseases caused by pathogenic organisms such as bacteria, viruses, protozoa,
More informationWGO Practice Guideline: Helicobacter pylori in Developing Countries
WGO Practice Guideline: Helicobacter pylori in Developing Countries Hp in Developing Countries 2 Review team Prof. R.H. Hunt, Chair (Canada) Prof. S.D. Xiao (China) Prof. F. Megraud (France) Prof. R. Leon-Barua
More informationModule 3 Questions. 7. Chemotaxis is an example of signal transduction. Explain, with the use of diagrams.
Module 3 Questions Section 1. Essay and Short Answers. Use diagrams wherever possible 1. With the use of a diagram, provide an overview of the general regulation strategies available to a bacterial cell.
More informationGLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS
GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/
More informationName Class Date. Figure 13 1. 2. Which nucleotide in Figure 13 1 indicates the nucleic acid above is RNA? a. uracil c. cytosine b. guanine d.
13 Multiple Choice RNA and Protein Synthesis Chapter Test A Write the letter that best answers the question or completes the statement on the line provided. 1. Which of the following are found in both
More informationIs H. pylori infection...
Is H. pylori infection... the culprit behind your stomach symptoms? What s really going on in your stomach? You may often have stomach symptoms that you blame on certain foods or stress. You may take over-the-counter
More informationDigestive System (continued) Digestive System. Stomach. Peptic Ulcer Disease
Digestive System Digestive System (continued) Responsible for breaking down food, absorbing nutrients, eliminating wastes Alimentary canal Also known as gastrointestinal tract Reaches from mouth to anus
More information3.0 Treatment of Infection
3.0 Treatment of Infection Antibiotics and Medicine National Curriculum Link SCN 3-13b SCN 3-20b HWB 3-15a HWB 3-16a HWB 3-17a Learning Outcomes All students will know: Most common infections will get
More informationA rapid-release 50-mg tablet-based 13 C-urea breath test for the diagnosis of Helicobacter pylori infection
Aliment Pharmacol Ther 2003; 17: 253 257. doi: 10.1046/j.0269-2813.2003.01417.x A rapid-release 50-mg tablet-based 13 C-urea breath test for the diagnosis of Helicobacter pylori infection W.M.WONG*,S.K.LAM*,K.C.LAI*,K.M.CHU,
More informationEnteric Septicemia of Catfish
Enteric Septicemia of Catfish Jesse Chappell Extension Fisheries Specialist Revised 2008 Enteric Septicemia of Catfish (ESC) has become one of the two most significant diseases of economic significance
More informationSummary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor)
EMA/662624/2015 Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor) This is a summary of the risk management plan (RMP) for Orkambi, which details the measures to be taken
More information156 Antibacterial agents
156 Antibacterial agents prontosil 158 Antibacterial agents Antibacterial agents which others. Antibacterial agents which act against cell metabolism (antimetabolites) 161 162 Antibacterial agents MeO
More informationTranscription in prokaryotes. Elongation and termination
Transcription in prokaryotes Elongation and termination After initiation the σ factor leaves the scene. Core polymerase is conducting the elongation of the chain. The core polymerase contains main nucleotide
More informationGenetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
More informationDiagnosis, Treatment and Prevention of Typhoid Fever in the Children of Bangladesh: A Microbiologist s View.
Diagnosis, Treatment and Prevention of Typhoid Fever in the Children of Bangladesh: A Microbiologist s View. Samir K Saha, Ph.D. Department of Microbiology Dhaka Shishu Hospital Bangladesh Typhoid Fever:Salmonella
More informationWhat is Helicobacter pylori? hat problems can H. pylori cause? Does H. pylori cause cancer? ight H. pylori even be good for us?
In association with: Primary Care Society for Gastroenterology INFORMATION ABOUT Helicobacter pylori? What is Helicobacter pylori? hat problems can H. pylori cause? Does H. pylori cause cancer? ight H.
More informationDisc Diffusion Susceptibility Methods
Disc Diffusion Susceptibility Methods Introduction When a filter paper disc impregnated with a chemical is placed on agar the chemical will diffuse from the disc into the agar. This diffusion will place
More informationTrasposable elements: P elements
Trasposable elements: P elements In 1938 Marcus Rhodes provided the first genetic description of an unstable mutation, an allele of a gene required for the production of pigment in maize. This instability
More informationHemophilia Care. Will there always be new people in the world with hemophilia? Will hemophilia be treated more effectively and safely in the future?
Future of This chapter provides answers to these questions: Will there always be new people in the world with hemophilia? Will hemophilia be treated more effectively and safely in the future? Will the
More informationA. Ketorolac*** B. Naproxen C. Ibuprofen D. Celecoxib
1. A man, 66 years of age, with a history of knee osteoarthritis (OA) is experiencing increasing pain at rest and with physical activity. He also has a history of depression and coronary artery disease.
More informationUrinary Tract Infections
Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of
More informationNursing 113. Pharmacology Principles
Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics
More informationANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I)
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus bacteraemia annual report, part I The format
More informationPeptic Ulcer Disease and H. pylori
Peptic Ulcer Disease and H. pylori National Digestive Diseases Information Clearinghouse What is a peptic ulcer? A peptic ulcer is a sore on the inner lining of the stomach or duodenum the first part of
More informationInhibit terminal acid secretion from parietal cells by blocking H + /K + - ATPase pump
Chris J. Taylor, Pharm.D., BCPS Clinical Pharmacist Phoenix VA Health Care System Review pharmacology of PPIs Discuss possible association between PPI use and development of the following: Pneumonia (community-acquired
More informationEnergy & Enzymes. Life requires energy for maintenance of order, growth, and reproduction. The energy living things use is chemical energy.
Energy & Enzymes Life requires energy for maintenance of order, growth, and reproduction. The energy living things use is chemical energy. 1 Energy exists in two forms - potential and kinetic. Potential
More informationBCH401G Lecture 39 Andres
BCH401G Lecture 39 Andres Lecture Summary: Ribosome: Understand its role in translation and differences between translation in prokaryotes and eukaryotes. Translation: Understand the chemistry of this
More informationA rapid, low-dose, 13 C-urea tablet for the detection of Helicobacter pylori infection before and after treatment
Aliment Pharmacol Ther 2003; 17: 793 798. doi: 10.1046/j.0269-2813.2003.01490.x A rapid, low-dose, 13 C-urea tablet for the detection of Helicobacter pylori infection before and after treatment L. GATTA*,
More information10. Treatment of peritoneal dialysis associated fungal peritonitis
10. Treatment of peritoneal dialysis associated fungal peritonitis Date written: February 2003 Final submission: July 2004 Guidelines (Include recommendations based on level I or II evidence) The use of
More informationDevelop an understanding of the differential diagnosis of pseudomembranous colitis
Update on Clostridium difficile Colitis Clostridium difficile infection has recently emerged in populations without any known risk factors. This presentation will focus on the historical background, diagnosis,
More informationTREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER
Press information for journalists only TREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER Why treat IBD? IBD describes a range of chronic diseases of the gastrointestinal system, encompassing Ulcerative
More informationC-Difficile Infection Control and Prevention Strategies
C-Difficile Infection Control and Prevention Strategies Adrienne Mims, MD MPH VP, Chief Medical Officer Adrienne.Mims@AlliantQuality.org 1/18/2016 1 Disclosure This educational activity does not have commercial
More informationCEFA-DROPS AND CEFA-TABS
Page 1 of 5 FORT DODGE ANIMAL HEALTH Division of Wyeth 800-5TH STREET N.W., P.O. BOX 518 FORT DODGE IA 50501 USA Telephone: 515-955-4600 Fax: 515-955-3730 Order Desk Telephone: 800-685-5656 Order Desk
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)
More informationThe EcoCyc Curation Process
The EcoCyc Curation Process Ingrid M. Keseler SRI International 1 HOW OFTEN IS THE GOLDEN GATE BRIDGE PAINTED? Many misconceptions exist about how often the Bridge is painted. Some say once every seven
More informationLecture 6. Regulation of Protein Synthesis at the Translational Level
Regulation of Protein Synthesis (6.1) Lecture 6 Regulation of Protein Synthesis at the Translational Level Comparison of EF-Tu-GDP and EF-Tu-GTP conformations EF-Tu-GDP EF-Tu-GTP Next: Comparison of GDP
More informationWelcome to Implementing Inquirybased Microbial Project. Veronica Ardi, PhD
Welcome to Implementing Inquirybased Microbial Project Veronica Ardi, PhD Microbiology Laboratory Courses CourseSmart: ebook resources http://instructors.coursesmart.com/ Microbiology Laboratory Courses
More informationPERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL
PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL Public Health Action 1. Educate the public, particularly parents of infants, about the dangers of whooping cough and the advantages of initiating immunization
More informationCOMPOSITION: Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.
APPROVED PACKAGE INSERT DALACIN C 150 mg CAPSULES SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): DALACIN C TM 150 mg (Capsules) COMPOSITION: Each capsule contains clindamycin hydrochloride equivalent
More informationAbsorption of Drugs. Transport of a drug from the GI tract
Absorption of Drugs Absorption is the transfer of a drug from its site of administration to the bloodstream. The rate and efficiency of absorption depend on the route of administration. For IV delivery,
More information4. DNA replication Pages: 979-984 Difficulty: 2 Ans: C Which one of the following statements about enzymes that interact with DNA is true?
Chapter 25 DNA Metabolism Multiple Choice Questions 1. DNA replication Page: 977 Difficulty: 2 Ans: C The Meselson-Stahl experiment established that: A) DNA polymerase has a crucial role in DNA synthesis.
More informationRecombinant DNA and Biotechnology
Recombinant DNA and Biotechnology Chapter 18 Lecture Objectives What Is Recombinant DNA? How Are New Genes Inserted into Cells? What Sources of DNA Are Used in Cloning? What Other Tools Are Used to Study
More informationTransfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.
Transfection Key words: Transient transfection, Stable transfection, transfection methods, vector, plasmid, origin of replication, reporter gene/ protein, cloning site, promoter and enhancer, signal peptide,
More informationGeneral Trends in Infectious Disease
General Trends in Infectious Disease Four phenomena underline the increase in ID problems: Aging population Increasing numbers of immunocompromised patients Increased mobility of the population Newly emerging
More informationFluoroquinolone-Resistant Helicobacter pylori strains Isolated from One Egyptian University Hospital: Molecular
26 P a g e Fluoroquinolone-Resistant Helicobacter pylori strains Isolated from One Egyptian University Hospital: Molecular Aspects MAYSAA EL SAYED ZAKI 1, WALAA OTHMAN 1, MAHMOUD ABDELWAHAB ALI 2, AHMED
More informationCystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program
Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and
More informationWHY IS THIS IMPORTANT?
CHAPTER 10 BACTERIAL GROWTH Eye of Science / Science Photo Library WHY IS THIS IMPORTANT? Increase in numbers is one of the requirements for infection. This increase is dependent upon bacterial growth.
More informationProbiotics for the Treatment of Adult Gastrointestinal Disorders
Probiotics for the Treatment of Adult Gastrointestinal Disorders Darren M. Brenner, M.D. Division of Gastroenterology Northwestern University, Feinberg School of Medicine Chicago, Illinois What are Probiotics?
More informationActivity 7.21 Transcription factors
Purpose To consolidate understanding of protein synthesis. To explain the role of transcription factors and hormones in switching genes on and off. Play the transcription initiation complex game Regulation
More informationThe Basics of Drug Resistance:
CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?
More informationMolecular Diagnosis of Hepatitis B and Hepatitis D infections
Molecular Diagnosis of Hepatitis B and Hepatitis D infections Acute infection Detection of HBsAg in serum is a fundamental diagnostic marker of HBV infection HBsAg shows a strong correlation with HBV replication
More informationANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I)
ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus Bacteraemia Annual Report, Part I The annual
More informationQuantitative HBV DNA measurements and the management of infected health care workers
Quantitative HBV DNA measurements and the management of infected health care workers A.A. van der Eijk Department of Virology, Erasmus MC, Rotterdam, the Netherlands Introduction Worldwide since 1970s,
More informationWhat can I eat? Peptic ulcers. What are peptic ulcers? What tests are needed? Will the ulcer come back? What causes a peptic ulcer?
In association with: INFORMATION ABOUT Peptic ulcers www.corecharity.org.uk What are peptic ulcers? What causes a peptic ulcer? How are NSAIDs and aspirin involved? How do I know if I ve got an ulcer?
More informationVITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS
39 Chapter 3 VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS Maxine Briggs TABLE OF CONTENTS I. Review of the
More informationrestriction enzymes 350 Home R. Ward: Spring 2001
restriction enzymes 350 Home Restriction Enzymes (endonucleases): molecular scissors that cut DNA Properties of widely used Type II restriction enzymes: recognize a single sequence of bases in dsdna, usually
More informationMicromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -
A Microbiology Services Company Lab Services Research - Consulting - Regulatory Company description is a microbiology services company specializing in antiinfective discovery and development for the pharmaceutical,
More informationAmerican College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
American Journal of Gastroenterology ISSN 0002-9270 C 2007 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2007.01393.x Published by Blackwell Publishing American College of Gastroenterology
More informationBiotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College
Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Primary Source for figures and content: Eastern Campus Tortora, G.J. Microbiology
More informationActivity 4 Long-Term Effects of Drug Addiction
Activity 4 Long-Term Effects of Drug Addiction Core Concept: Addictive drugs may lead to long-term changes in brain function. Class time required: Approximately 60-80 minutes Teacher Provides: Copy of
More informationThe Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin
The Journal of International Medical Research 1995; 23: 386-393 The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin T ERDOGRU\ A AGA9FIDAff, M ONELz,S BADUR z, 0 ANG 2 AND S TELALLOGLU
More informationMedical Microbiology Culture Media :
Lecture 3 Dr. Ismail I. Daood Medical Microbiology Culture Media : Culture media are used for recognition and identification (diagnosis) of microorganisms. The media are contained in plates (Petri dishes),
More informationWhat are peptic ulcers?
Information about Peptic ulcers www.corecharity.org.uk What are the symptoms? What are the causes? What are peptic ulcers? When should I consult a doctor? What will the doctor do? How should I treat peptic
More informationThe background behind Matula Herbal Formula
(Available in Packs of 60 Sachets equivalent to a full 30 day treatment) The background behind Matula Herbal Formula Matula Herbal Formula was discovered in 1998 and has successfully served the global
More informationAntimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection
Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection Emi Minejima, PharmD Assistant Professor of Clinical Pharmacy USC School of Pharmacy minejima@usc.edu
More informationGROWING BACTERIA INTRODUCTION
GROWING BACTERIA INTRODUCTION E. coli is a normal part of the bacterial flora of the human gut. It is not generally considered pathogenic, although some strains are highly toxic (recent food poisonings
More informationLessons from the Stanford HIV Drug Resistance Database
1 Lessons from the Stanford HIV Drug Resistance Database Bob Shafer, MD Department of Medicine and by Courtesy Pathology (Infectious Diseases) Stanford University Outline 2 Goals and rationale for HIVDB
More informationNursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection
L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after
More informationAn overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham
An overview of CLL care and treatment Dr Dean Smith Haematology Consultant City Hospital Nottingham What is CLL? CLL (Chronic Lymphocytic Leukaemia) is a type of cancer in which the bone marrow makes too
More informationTroubleshooting the Single-step PCR Site-directed Mutagenesis Procedure Intended to Create a Non-functional rop Gene in the pbr322 Plasmid
Troubleshooting the Single-step PCR Site-directed Mutagenesis Procedure Intended to Create a Non-functional rop Gene in the pbr322 Plasmid Lina Jew Department of Microbiology & Immunology, University of
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationPertussis Information for GPs and other Health Care Providers on Clinical and Public Health Management. March 2010
Pertussis Information for GPs and other Health Care Providers on Clinical and Public Health Management March 2010 Infectious Agent Bordetella pertussis (a bacterium) Clinical Features Infants and Young
More informationCHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA
CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA INTRODUCTION DNA : DNA is deoxyribose nucleic acid. It is made up of a base consisting of sugar, phosphate and one nitrogen base.the
More information